Antifungal Drugs market is Booming Worldwide at a Significant Growth of 3.9% CAGR by 2030

According to the report, the global antifungal drugs market size was valued at $16.6 billion in 2020, and is projected to reach $25.0 billion by 2030, growing at a CAGR of 3.9% from 2021 to 2030.

In detail along with the table of contents, please click on the link below:

https://www.alliedmarketresearch.com/request-sample/2370

Antifungal drugs to primarily cater the systemic antifungal infections

By infection type, the systemic antifungal segment is expected to maintain its dominant position through 2030 and occupy almost 70% of the global market. This is attributed to their increased demand owing to their bioavailability, efficacy, and enhanced ability to provide better treatment against a broad spectrum of fungi that affects the internal organs severely.

Favorable government funds to combat the antifungal diseases along with the increasing prevalence of fungal infection drive the growth of the market. Furthermore, rising awareness levels pertaining to myriad fungal infections supplement the market growth. However, the growing population with antifungal drug resistance and the presence of counterfeit drugs and side effects of antifungal drugs restrict the growth. On the other hand, patent expirations and increasing funding from public & private organizations offer lucrative opportunities for the market.

Market Drivers:

Increasing Incidence of Fungal Infections: The growing prevalence of fungal infections worldwide is a significant driver for the antifungal drugs market. Factors such as the rising number of immunocompromised patients (due to conditions like HIV/AIDS, cancer, organ transplantation, etc.), aging population, and the use of broad-spectrum antibiotics contribute to the higher risk of fungal infections.

Rising Awareness and Improved Diagnosis: There has been an increase in awareness among healthcare professionals and the general population about the risks and consequences of fungal infections. This has led to improved diagnosis and early detection of fungal infections, driving the demand for antifungal drugs. Advanced diagnostic techniques such as molecular diagnostics and biomarker-based assays aid in accurate and timely identification of fungal infections.

Technological Advancements and Product Innovations: Advances in technology have facilitated the development of new antifungal drugs with improved efficacy, safety, and patient convenience. Pharmaceutical companies are investing in research and development to discover novel drug targets and develop innovative antifungal therapies. This includes the development of new formulations, combination therapies, and improved drug delivery systems.

Request for Customization -

https://www.alliedmarketresearch.com/request-for-customization/2370

Regional Growth Dynamics:

North America contributed to the highest share in terms of revenue in 2020, holding more than two-fifths of the total market share, and is estimated to continue its dominant share by 2030. However, Asia-Pacific is projected to manifest the fastest CAGR of 5.2% during the forecast period.

Competitive Landscape:

Pfizer Inc.
Novartis AG
Merck & Co., Inc.
Johnson & Johnson
Astellas Pharma Inc.
GlaxoSmithKline plc
AbbVie Inc.
Sanofi
Bayer AG
Mylan N.V.

Buy this Premium Research Report:

https://www.alliedmarketresearch.com/purchase-enquiry/2370

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

Distributor Landscape Assessment
Pricing Intelligence
Customer Base Assessment
Investment & Initiatives Analysis
'Business Profile' of Key Players

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the

https://www.alliedmarketresearch.com/library-access

Browse more latest healthcare reports:

Urinary Incontinence Devices Market https://www.alliedmarketresearch.com/urinary-incontinence-devices-market

Medical Batteries Market https://www.alliedmarketresearch.com/medical-batteries-market-A08391

Influenza Vaccine Market https://www.alliedmarketresearch.com/influenza-vaccines-market

Contact Data
David Correa

1209 Orange Street, Corporation Trust Center, Wilmington, New Castle, Delaware 19801 USA.

Toll Free: +1-800-792-5285| Int'l: +1-503-894-6022

UK: +44-845-528-1300| Hong Kong: +852-301-84916

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.